Cargando…

Rapid-acting oral drug (Auvelity) for major depressive disorder

Detalles Bibliográficos
Autores principales:	Khabir, Yumna, Hashmi, Mahnoor Rehan, Ali Asghar, Adam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577655/ https://www.ncbi.nlm.nih.gov/pubmed/36268350 http://dx.doi.org/10.1016/j.amsu.2022.104629

Ejemplares similares

Kyzatrex - Oral testosterone replacement therapy
por: Asghar, Adam Ali, et al.
Publicado: (2022)

FlexBurst360 therapy – A new spine cord stimulation system (SCS) for patients with chronic pain
por: Khabir, Yumna, et al.
Publicado: (2022)

Zynteglo: Betibeglogene autotemcel – An innovative therapy for β- thalassemia patients
por: Asghar, Adam Ali, et al.
Publicado: (2022)

Dextromethorphan-bupropion (Auvelity) for the Treatment of Major Depressive Disorder
por: McCarthy, Brian, et al.
Publicado: (2023)

Odds of HIV among incarcerated drug users: a systematic review and meta-analysis of Asian countries
por: Hussain, Hassan ul, et al.
Publicado: (2023)

Differential expression of MDGA1 in major depressive disorder
por: Li, Yijie (Jamie), et al.
Publicado: (2022)

Is postnatal depression a distinct subtype of major depressive disorder? An exploratory study
por: O’ Brien, Suzanne, et al.
Publicado: (2020)

Reduced Sulcal Depth in Central Sulcus of Major Depressive Disorder
por: Shin, Seung-Joon, et al.
Publicado: (2022)

Memory mood congruency phenomenon in bipolar I disorder and major depression disorder patients
por: Delgado, V.B., et al.
Publicado: (2012)

Exercise Addiction and Major Depressive Disorder – Clinical Diagnoses and Longitudinal Course
por: Tschopp, Amos, et al.
Publicado: (2023)

The Association of White Matter Tracts with Alexithymia among Individuals with Major Depressive Disorder
por: Kang, Youbin, et al.
Publicado: (2022)

The Indirect Effect of Prefrontal Gray Matter Volume on Suicide Attempts among Individuals with Major Depressive Disorder
por: Kang, June, et al.
Publicado: (2022)

An Overview of Reviews on the Effects of Acceptance and Commitment Therapy (ACT) on Depression and Anxiety
por: Beygi, Zahra, et al.
Publicado: (2023)

Effect of Escitalopram on White Blood Cells in Patients With Major Depression
por: Canan, Fatih, et al.
Publicado: (2009)

Pegcetacoplan ‐ a novel C3 inhibitor for paroxysmal nocturnal hemoglobinuria
por: Rehan, Syeda Tayyaba, et al.
Publicado: (2022)

No association between major depression with and without childhood adversity and the stress hormone copeptin
por: Kaczmarczyk, Michael, et al.
Publicado: (2020)

Rapid response to selective serotonin reuptake inhibitors in post-COVID depression
por: Mazza, Mario Gennaro, et al.
Publicado: (2022)

Absence of zygomycetes in the oral niche of patients with oral squamous cell carcinoma and oral potentially malignant disorders
por: Mahalakshmi, Krishnan, et al.
Publicado: (2022)

Machine learning algorithm accurately detects fMRI signature of vulnerability to major depression
por: Sato, João R., et al.
Publicado: (2015)

Modulation of amygdala reactivity following rapidly acting interventions for major depression
por: Loureiro, Joana R. A., et al.
Publicado: (2020)

Assessment of major mental disorders in a German peripartum cardiomyopathy cohort
por: Pfeffer, Tobias J., et al.
Publicado: (2020)

Efficacy of mindfulness-based intervention for the treatment of chronic headaches: A systematic review and meta-analysis
por: Aemaz Ur Rehman, Muhammad, et al.
Publicado: (2022)

Vortioxetine improves physical and cognitive symptoms in patients with post-COVID-19 major depressive episodes
por: Di Nicola, Marco, et al.
Publicado: (2023)

Depression and anxiety in pregnancy during COVID-19: A rapid review and meta-analysis
por: Tomfohr-Madsen, Lianne M., et al.
Publicado: (2021)

BDNF rs962369 Is Associated with Major Depressive Disorder
por: Bednářová, Aneta, et al.
Publicado: (2023)

Screening of oral potentially malignant disorders: Need of the hour
por: Jeddy, Nadeem, et al.
Publicado: (2017)

Metabolomic signatures of drug response phenotypes for ketamine and esketamine in subjects with refractory major depressive disorder: new mechanistic insights for rapid acting antidepressants
por: Rotroff, D M, et al.
Publicado: (2016)

Water and ethanol extracts of Plantago major leaves show anti-inflammatory activity on oral epithelial cells
por: Zubair, Muhammad, et al.
Publicado: (2018)

Ovine rumen papillae biopsy via oral endoscopy; a rapid and repeatable method for serial sampling
por: McRae, KM, et al.
Publicado: (2016)

Universal pro forma for the oral potentially malignant disorders: Need of the hour
por: Desai, Rajiv S
Publicado: (2021)

The ten steps for acting on health inequalities
por: Kelly, Michael P., et al.
Publicado: (2023)

Add-on quetiapine in the treatment of major depressive disorder in elderly patients with cerebrovascular damage
por: Carta, Mauro Giovanni, et al.
Publicado: (2007)

Treating winter depressive episodes in bipolar disorder: an open trial of light therapy
por: van Hout, Lotte J. E., et al.
Publicado: (2020)

MTORC1 signaling as a biomarker in major depressive disorder and its pharmacological modulation by novel rapid-acting antidepressants
por: Cholewinski, Tomasz, et al.
Publicado: (2021)

The Cholera outbreak in Karachi, Pakistan: Challenges, efforts and recommendations
por: Khan, Hira Anas, et al.
Publicado: (2022)

Drug Resistance of Pseudomonas aeruginosa and Enterobacter cloacae Isolated from ICU, Babol, Northern Iran
por: Bayani, Masoomeh, et al.
Publicado: (2013)

Prevalence of oral potentially malignant disorders and oral malignant lesions: A population-based study in a municipal town of southern Kerala
por: Sivakumar, T T, et al.
Publicado: (2018)

Management of major depression in outpatients attending a cancer centre: a preliminary evaluation of a multicomponent cancer nurse-delivered intervention
por: Sharpe, M, et al.
Publicado: (2004)

A GWAS top hit for circulating leptin is associated with weight gain but not with leptin protein levels in lithium-augmented patients with major depression
por: Bopp, Sandra K, et al.
Publicado: (2021)

Depression as a major determinant of PASS (Patient’s Acceptable Symptoms State) in rheumatoid arthritis: a cross-sectional study in Brazilian patients
por: Stocker, Paulo Henrique, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b9tc2et3atck8p3ei6mjchnspj